Article
Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
Clinical colorectal cancer - 1 Aug 2001
Belly R T, Rosenblatt J D, Steinmann M, Toner J, Sun J, Shehadi J, Peacock J L, Raubertas R F, Jani N, Ryan C K
Abstract excerpt
Stage II colorectal carcinoma is characterized by negative lymph node pathology as determined by conventional microscopic examination. These patients generally do not receive adjuvant therapy although 20%-30% will die from metastatic disease. To determine whether K-ras mutations at codon 12 could be used as a sensitive indicator of occult lymph node metastasis in stage II colon carcinoma, a retrospective study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
